Only the Acetylcholinesterase enzyme inhibitors (AChE) and N-methyl d-aspartate (NMDA) antagonists are the FDA approved drugs for AD and they only improve the symptoms but do not prevent the progression of AD22,23. This evidence concerns the gene ACHE and Alzheimer disease.